Interleukin-1 and related cytokines in the regulation of inflammation and immunity A Mantovani, CA Dinarello, M Molgora, C Garlanda Immunity 50 (4), 778-795, 2019 | 957 | 2019 |
TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy M Molgora, E Esaulova, W Vermi, J Hou, Y Chen, J Luo, S Brioschi, ... Cell 182 (4), 886-900. e17, 2020 | 493 | 2020 |
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer E Bonavita, S Gentile, M Rubino, V Maina, R Papait, P Kunderfranco, ... Cell 160 (4), 700-714, 2015 | 409 | 2015 |
Single-cell sequencing of mouse heart immune infiltrate in pressure overload–driven heart failure reveals extent of immune activation E Martini, P Kunderfranco, C Peano, P Carullo, M Cremonesi, T Schorn, ... Circulation 140 (25), 2089-2107, 2019 | 282 | 2019 |
Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors A Ponzetta, R Carriero, S Carnevale, M Barbagallo, M Molgora, ... Cell 178 (2), 346-360. e24, 2019 | 229 | 2019 |
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity M Molgora, E Bonavita, A Ponzetta, F Riva, M Barbagallo, S Jaillon, ... Nature 551 (7678), 110-114, 2017 | 213 | 2017 |
Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer E Timperi, P Gueguen, M Molgora, I Magagna, Y Kieffer, S Lopez-Lastra, ... Cancer research 82 (18), 3291-3306, 2022 | 144 | 2022 |
Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1β, IFN-β, and IL-15 pathways I Mattiola, M Pesant, PF Tentorio, M Molgora, E Marcenaro, E Lugli, ... The Journal of Immunology 195 (6), 2818-2828, 2015 | 122 | 2015 |
The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell–mediated resistance to metastasis I Mattiola, F Tomay, M De Pizzol, R Silva-Gomes, B Savino, T Gulic, ... Nature immunology 20 (8), 1012-1022, 2019 | 121 | 2019 |
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 108 | 2023 |
Tuning inflammation and immunity by the negative regulators IL‐1R2 and IL‐1R8 M Molgora, D Supino, A Mantovani, C Garlanda Immunological Reviews 281 (1), 233-247, 2018 | 97 | 2018 |
Regulatory role of IL-1R8 in immunity and disease M Molgora, I Barajon, A Mantovani, C Garlanda Frontiers in immunology 7, 149, 2016 | 78 | 2016 |
Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity F Bonacina, A Moregola, R Porte, A Baragetti, E Bonavita, A Salatin, ... Cardiovascular Research 115 (13), 1861-1872, 2019 | 47 | 2019 |
The yin‐yang of the interaction between myelomonocytic cells and NK cells M Molgora, D Supino, D Mavilio, A Santoni, L Moretta, A Mantovani, ... Scandinavian journal of immunology 88 (3), e12705, 2018 | 46 | 2018 |
Exploring the impact of TREM2 in tumor-associated macrophages D Khantakova, S Brioschi, M Molgora Vaccines 10 (6), 943, 2022 | 39 | 2022 |
IL-1 and related cytokines in innate and adaptive immunity in health and disease A Mantovani, CA Dinarello, M Molgora, C Garlanda Immunity 50 (4), 778, 2019 | 39 | 2019 |
The fibronectin–ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells KJ Paavola, JM Roda, VY Lin, P Chen, KP O'Hollaren, R Ventura, ... Cancer immunology research 9 (11), 1283-1297, 2021 | 38 | 2021 |
Turning enemies into allies—Reprogramming tumor-associated macrophages for cancer therapy M Molgora, M Colonna Med 2 (6), 666-681, 2021 | 38 | 2021 |
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity LF Campesato, APM Silva, L Cordeiro, BR Correa, FCP Navarro, ... Oncotarget 8 (30), 49470, 2017 | 36 | 2017 |
A Cre-deleter specific for embryo-derived brain macrophages reveals distinct features of microglia and border macrophages S Brioschi, JA Belk, V Peng, M Molgora, PF Rodrigues, KM Nguyen, ... Immunity 56 (5), 1027-1045. e8, 2023 | 34 | 2023 |